Broncus Medical

BRONCUS MEDICAL INC. specializes in the development of diagnostic and therapeutic technologies for lung diseases, focusing on minimally-invasive solutions. The company's product portfolio includes the Archimedes System, which facilitates lung access and navigation for procedures such as biopsies; the Lungpoint Virtual Bronchoscopic Navigation system, which provides real-time navigation within the lungs; and the Flexneedle, a tool for transbronchial aspiration. BRONCUS is also investigating the Exhale emphysema product line, which aims to deliver a patented minimally-invasive treatment method known as Airway Bypass, targeting severe homogeneous emphysema, a common condition among emphysema patients. The company is conducting a pivotal clinical trial, the EASE Trial, to evaluate this treatment. Headquartered in San Jose, California, BRONCUS has an additional office in Shanghai, China, and operates an international branch in Switzerland.